Sign in

CIK 0001287098

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

MAXCYTE, INC.

Sign in to watch
Ticker
MXCT
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
522210438
Phone
+1 301-517-5556
Business address
9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
Former names
MAXCYTE INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-06-29 Hemrajani Rekha Director Grant or award · Stock Option (right to buy) +26,900 26,900
2022-06-29 Johnston John Joseph Director Grant or award · Stock Option (right to buy) +26,900 26,900
2022-06-29 Mandell Art Director Grant or award · Stock Option (right to buy) +26,900 26,900
2022-04-11 Sumen Cenk Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +500,000 500,000
2022-03-25 Masoud Maher EVP and General Counsel Grant or award · Employee Stock Option (right to buy) +242,000 242,000
2022-03-25 Ross Thomas M. EVP, Global Sales & Marketing Grant or award · Employee Stock Option (right to buy) +142,000 142,000
2022-03-25 Holtz Ron SVP and CAO Grant or award · Employee Stock Option (right to buy) +142,000 142,000
2022-03-25 Murphy Amanda Louise Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +142,000 142,000
2022-03-25 Doerfler Douglas President and CEO Grant or award · Employee Stock Option (right to buy) +500,000 500,000
2021-11-22 DOUGLAS RICHARD Director Purchase +20,000 $11.12 $222K 20,000
2021-11-16 Masoud Maher EVP and General Counsel Exercise or conversion +18,562 $3.25 $60K 18,562
2021-11-16 Masoud Maher EVP and General Counsel Sale −18,562 $12.08 $224K 0
2021-11-16 Masoud Maher EVP and General Counsel Exercise or conversion · Employee Stock Option (right to buy) −18,562 0
2021-11-16 Murphy Amanda Louise Chief Financial Officer Exercise or conversion +37,306 $4.42 $165K 37,306
2021-11-16 Murphy Amanda Louise Chief Financial Officer Sale −37,306 $12.08 $451K 0
2021-11-16 Murphy Amanda Louise Chief Financial Officer Exercise or conversion · Employee Stock Option (right to buy) −37,306 1,000,000
2021-11-16 Ross Thomas M. EVP, Global Sales Exercise or conversion +31,163 $0.84 $26K 31,163
2021-11-16 Ross Thomas M. EVP, Global Sales Sale −31,163 $12.08 $376K 0
2021-11-16 Ross Thomas M. EVP, Global Sales Exercise or conversion · Employee Stock Option (right to buy) −31,163 57,000
2021-11-16 Holtz Ron SVP and CAO Exercise or conversion +39,130 $0.04 $2K 164,381

Page 18 of 21 · 411 trades